Observational study / 2013
Weight loss in obese individuals was linked to increasing serum levels of organohalogenated contaminants released from adipose tissue.
Researchers tracked the dynamics of organohalogenated contaminants (OHCs) and their metabolites in obese individuals before weight loss and after 3, 6, and 12 months, comparing them with matched lean controls. At baseline, obese individuals had significantly lower concentrations of major PCBs, their metabolites, and PCP compared to controls. During weight loss, increasing serum levels were observed for all OHCs, with release from adipose tissue appearing dependent on the octanol-water partition coefficient. The authors noted that weight loss influences the release and metabolism of OHCs, raising potential concern over increased levels of endocrine-disrupting compounds.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study with matched controls
- Who was studied
- Obese individuals undergoing weight loss treatment and a matched lean control population
- What was measured
- Serum concentrations and profiles of organohalogenated contaminants (OHCs) and metabolites across 12 months
THE PAPER
Dynamics of organohalogenated contaminants in human serum from obese individuals during one year of weight loss treatment.
Dirtu AC, Dirinck E, Malarvannan G, Neels H, Van Gaal L, Jorens PG, Covaci A. Environ Sci Technol, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.